REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

AsiaGen Corporation (亚洲基因科技股份有限公司) (Taiwan, China)

Main Activities: Medical Equipment and Supplies Manufacturing
Full name: AsiaGen Corporation Profile Updated: August 16, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Asiagen Corporation is a company that focuses on regenerative medicine, detection reagents, and stem cell extraction. They offer services in cell storage and immunicals. The company operates in the health industry and targets the regenerative medicine segment.

Headquarters
No,312, Xiaoxinying, Shanhua Dist
Tainan City; Tainan City;

Contact Details: Purchase the AsiaGen Corporation (亚洲基因科技股份有限公司) report to view the information.

Website: http://www.asiagen.com.tw

Basic Information
Total Employees:
Purchase the AsiaGen Corporation (亚洲基因科技股份有限公司) report to view the information.
Outstanding Shares:
Purchase the AsiaGen Corporation (亚洲基因科技股份有限公司) report to view the information.
Financial Auditors:
Purchase the AsiaGen Corporation (亚洲基因科技股份有限公司) report to view the information.
Incorporation Date:
March 14, 2000
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
3.35%
Purchase this report to view the information.
2.94%
Purchase this report to view the information.
1.17%
Purchase this report to view the information.
0.49%
Purchase this report to view the information.
0.4%
Subsidiaries
Leader Hill Limited
100%
Company Performance
Financial values in the chart are available after AsiaGen Corporation (亚洲基因科技股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
154.27%▲
Total operating revenue
149.9%▲
Operating Profit/Loss (EBIT)
29.51%▲
EBITDA
33.4%▲
Net Profit/Loss for the Period
20.11%▲
Total Assets
-15.13%▼
Total Equity
-15.25%▼
Operating Profit Margin (ROS)
364%▲
Net Profit Margin
361.3%▲
Return on Equity (ROE)
1.1%▲
Debt/Equity
-0.53%▼
Quick Ratio
-1.48%▼
Cash Ratio
-1.04%▼

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo